A Method for Rapid, Reliable, and Low-Volume Measurement of Lithium in Blood for Use in Bipolar Disorder Treatment Management
- Submitting institution
-
City, University of London
- Unit of assessment
- 12 - Engineering
- Output identifier
- 444
- Type
- D - Journal article
- DOI
-
10.1109/TBME.2018.2836148
- Title of journal
- IEEE Transactions on Biomedical Engineering
- Article number
- -
- First page
- 130
- Volume
- 66
- Issue
- 1
- ISSN
- 0018-9294
- Open access status
- Exception within 3 months of publication
- Month of publication
- May
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
5
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- This paper was selected as a “featured article” in December 2018 as it proposed a novel method for rapid and accurate measurement of lithium levels in blood. Around 1% of the UK’s population suffer from Bipolar disorder. Whilst lithium medication is known to alleviate the symptoms of Bipolar disorder and reduce the risk of suicide, it is potentially a toxic drug with a very narrow therapeutic range. The paper proposed a method that can potentially eliminate falling monitoring targets of lithium in Bipolar patients thereby enabling frequent and reliable self-monitoring by patients to maintain safe and therapeutic medication levels
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
